James Condulis
Stock Analyst at Stifel
(2.21)
# 2,824
Out of 4,966 analysts
5
Total ratings
50%
Success rate
11.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $24.05 | +82.95% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $67.67 | +59.60% | 2 | Mar 28, 2025 | |
| CYTK Cytokinetics | Initiates: Buy | $80 | $35.33 | +126.44% | 1 | Jan 22, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $14.35 | +109.06% | 1 | Jan 22, 2025 |
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $24.05
Upside: +82.95%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $67.67
Upside: +59.60%
Cytokinetics
Jan 22, 2025
Initiates: Buy
Price Target: $80
Current: $35.33
Upside: +126.44%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $14.35
Upside: +109.06%